Best Practice & Research in Clinical Rheumatology

Papers
(The TQCC of Best Practice & Research in Clinical Rheumatology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The importance of functional genomics studies in precision rheumatology106
Novel therapies – IMID Co-morbidities93
Update of imaging in the assessment of axial spondyloarthritis86
CAR T-cell therapy and indications for pediatric rheumatology83
Predicting and preventing clinical psoriatic arthritis63
Raynaud's phenomenon and digital ulceration in systemic sclerosis51
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit49
Possible future avenues for myositis therapeutics: DM, IMNM and IBM47
Chimeric antigen receptor T-cell (CAR-T) therapy and other cellular immunotherapy treatments for idiopathic inflammatory myopathies46
Rehabilitation interventions in osteoarthritis45
Epidemiology of rheumatic diseases in tropical populations42
Rheumatic manifestations of HIV/AIDS41
The inequity of global healthcare in pediatric rheumatology37
Environmental factors and rheumatic diseases35
Erratum to “Editorial Board” [Best Pract Res Clin Rheumatol (2025) 102094]34
Novel therapies in Sjögren’s disease: A systematic review of the literature29
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus29
Pathophysiology and immunolgical basis of axial spondyloarthritis29
New age of Lupus Nephritis: Updates in guidelines, biomarkers, and therapies29
Novel therapies for axial spondyloarthritis and future directions28
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus26
Index for PART A26
Oral and maxillofacial manifestations of systemic sclerosis26
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases25
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis25
Genetics of osteoarthritis24
Global epidemiology of psoriatic arthritis24
Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis?24
Decoding pain in axial spondyloarthritis: Mechanisms, management, and future directions24
Genetics of rheumatoid arthritis24
Editorial Board23
Patient-reported outcomes in vasculitis23
Osteoporosis in 2022: Care gaps to screening and personalised medicine23
Novel therapies and innovation for systemic sclerosis skin ulceration23
The challenges in managing Psoriatic Arthritis in resource poor settings23
Index22
Editorial Board22
CAR T cell therapy: Autoimmune neurological uses and neurotoxicities21
Preclinical RA: How to halt its progression21
Editorial Board20
Diagnostic delay in axial spondylarthritis: A lost battle?20
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps20
Where is bone science taking us?20
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?20
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights20
Systemic lupus erythematosus20
Imaging of crystal-induced arthropathies in 202520
The burden of osteoarthritis: Is it a rising problem?20
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists19
Pregnancy & neonatal outcomes in spondyloarthritis19
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome19
Improving quality of care in systemic sclerosis19
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment18
New and future therapies: Changes in the therapeutic armamentarium for SLE18
Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management18
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues18
Malignancy and rheumatic diseases17
Novel therapies in treatments of SLE17
Infection associated Vasculitides17
Problems with “Problems with opioids beyond misuse”17
Imaging rheumatology: Emerging tools and expanding applications17
CAR-T cell therapy for ANCA-associated vasculitis: Rationale, current evidence, and future directions15
Exercise in myositis: What is important, the prescription or the person?14
Pregnancy in systemic lupus erythematosus14
Editorial Board14
Granzyme K+ CD8 T cells in autoimmunity14
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances13
Editorial Board13
Risk for osteoporosis and fracture with glucocorticoids13
Index12
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment12
0.077774047851562